Development of a Novel Amino Acid PET Probe for Imaging Diagnosis of Early Stage Pancreatic Cancer -Exploratory study of protein expression in pancreatic diseases-

Development of a Novel Amino Acid PET Probe for Imaging Diagnosis of Early Stage Pancreatic Cancer -Exploratory study of protein expression in pancreatic diseases- - Development of an Amino Acid PET Probe for Imaging Diagnosis of Pancreatic Cancer -Exploratory study of protein expression in pancreatic diseases-

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050758

Enrollment

Registered

2024-04-04

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, and other pancreatic diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: About 70 cases of surplus pathology samples of the pancreas removed by surgery and biopsy from patients with pancreatic cancer (including precancerous lesions) or other pancreatic diseases (benign diseases) who obtained comprehensive informed consent at Kanagawa Cancer Center from January 1, 2010 to December 1, 2022, after diagnosis by the Department of Pathology.

Exclusion criteria

Exclusion criteria: If the research subject or his/her representative refuses the use of the tissue pathology specimen for this research after opting out at National Institutes for Quantum Science and Technology and Kanagawa Cancer Center.

Design outcomes

Primary

Measure	Time frame
Comparison of protein expression degrees in benign pancreatic disease, precancerous lesions, and pancreatic cancer lesions	—

Countries

Japan

Contacts

Public ContactAtsushi Tsuji

Institute for Quantum Medical Science, QST Dept. of Molecular Imaging and Theranostics

tsuji.atsushi@qst.go.jp0432063402

Outcome results